Jun 3 |
Johnson & Johnson acquires Shockwave in $13.1bn deal
|
May 30 |
Here’s Why Shockwave Medical (SWAV) Surged in Q1
|
May 29 |
Sarepta Therapeutics Set to Join S&P MidCap 400
|
May 21 |
Shockwave Medical gains after HSR waiting period for sale to J&J expires
|
May 17 |
Elixir’s focal stress system to treat calcified lesions hits success in trial
|
May 16 |
Shockwave Medical: A Look Into Q1 Financials And Value To Johnson & Johnson Investors
|
May 7 |
Shockwave Medical (SWAV) Q1 Earnings Beat, Revenues Rise Y/Y
|
May 7 |
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|
May 7 |
Beyond the Balance Sheet: What SWOT Reveals About Shockwave Medical Inc (SWAV)
|
May 7 |
Shockwave Medical (SWAV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
|